LEADER 03882nam 2200637 450 001 9910795981103321 005 20240112051739.0 010 $a1-5036-3407-8 024 7 $a10.1515/9781503634077 035 $a(MiAaPQ)EBC30160944 035 $a(Au-PeEL)EBL30160944 035 $a(CKB)24949928900041 035 $a(DE-B1597)632960 035 $a(DE-B1597)9781503634077 035 $a(OCoLC)1353270049 035 $a(EXLCZ)9924949928900041 100 $a20240112d2023 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aMaking sense $emarkets from stories in new breast cancer therapeutics /$fSophie Mu?tzel 205 $aFirst edition. 210 1$aStanford, California :$cStanford University Press,$d[2023] 210 4$d©2023 215 $a1 online resource (222 pages) 225 1 $aCulture and economic life 311 08$aPrint version: Mützel, Sophie Making Sense Sundridge : Stanford University Press,c2022 9781503634060 320 $aIncludes bibliographical references and index. 327 $tFrontmatter --$tContents --$tAcknowledgments --$tIntroduction --$t1 Markets and Stories --$t2 Breast Cancer Therapies and Innovation --$t3 A Market of Expectations --$t4 Making Sense of the Market --$t5 Patterns in Meaning-Making: Categories over Time --$tConclusion: Markets from Stories --$tAppendix A: Research Design and Data --$tAppendix B: Technical Details on Formal Analyses --$tNotes --$tBibliography --$tIndex 330 $aBreast cancer is one of the most commonly diagnosed cancers and a leading cause of death for women worldwide. With advances in molecular engineering in the 1980s, hopes began to rise that a non-toxic and non-invasive treatment for breast cancer could be developed. These hopes were stoked by the researchers, biotech companies, and analysts who worked to make sense of the uncertainties during product development. In Making Sense Sophie Mützel traces this emergence of "innovative breast cancer therapeutics" up to the 2010s, through the lens of the narratives of the involved actors. Despite the notorious unpredictability of cancer drug development these actors are tasked with establishing a client base and capturing the attention of potential investors, even before trials are completed. Combining theories of economic and cultural sociology, Mützel shows how stories are integral for the emergence of new markets; stories of the future create a market of expectations prior to any existing products. Making Sense uses thousands of press statements, media reports, scientific reports, and financial and industry analyses to illustrate these mechanisms, presenting a fresh view of how life-prolonging innovations can be turned into market products. 410 0$aCulture and economic life. 606 $aPharmaceutical biotechnology industry 606 $aBreast$xCancer$xTreatment$xTechnological innovations 606 $aBreast$xCancer$xTreatment$xEconomic aspects 606 $aDrug development$xEconomic aspects 606 $aNarration (Rhetoric)$xEconomic aspects 606 $aNarration (Rhetoric)$xSocial aspects 606 $aMarkets$xSocial aspects 615 0$aPharmaceutical biotechnology industry. 615 0$aBreast$xCancer$xTreatment$xTechnological innovations. 615 0$aBreast$xCancer$xTreatment$xEconomic aspects. 615 0$aDrug development$xEconomic aspects. 615 0$aNarration (Rhetoric)$xEconomic aspects. 615 0$aNarration (Rhetoric)$xSocial aspects. 615 0$aMarkets$xSocial aspects. 676 $a616.99449061 700 $aMu?tzel$b Sophie$01464236 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910795981103321 996 $aMaking sense$93673810 997 $aUNINA